China: Oculis appoints Ding as global COO and General Manager, China

Switzerland-headquartered Oculis, a late-stage biopharmaceutical company focused on developing ophthalmic treatments, has appointed Webb Ding as global COO and General Manager, China. He takes up the role from February 1, 2022. Ding brings healthcare leadership experience, with a specific focus on the China market. He has more than 25 years of experience in general management,…

You must be a HMI Subscriber to view this content.

Login » Subscribe Now »

Advertisement